BIN1 and pancreatic neoplasm: BIN1 expression is reduced or absent in many human cancers, including esophageal, gastric, neuroblastoma, breast, lung, colorectal, prostate, pancreatic cancers, and malignant pleural mesothelioma [18, 35–39]., making it an important focus in cancer research.